[Parkinson's disease: dealing with all dimensions of the disease].
Fénelon
Gilles
G
Service de neurologie et équipe A venir Inserm U421, hôpital Henri Mondor, 94010 Créteil Cedex. gilles.fenelon@hmn.aphp.fr
D015316:Genetic Therapy; D051100:Glial Cell Line-Derived Neurotrophic Factor; D006801:Humans; D009414:Nerve Growth Factors / Q000627:therapeutic use; D018696:Neuroprotective Agents / Q000627:therapeutic use; D010300:Parkinson Disease / Q000209:etiology / Q000628:therapy*
C495039:GDNF protein, human; D051100:Glial Cell Line-Derived Neurotrophic Factor; D009414:Nerve Growth Factors; D018696:Neuroprotective Agents